GSK973
Product Specifications
CAS Number
2138473-38-6
Target
Epigenetic Reader Domain, Others
Related Pathways
Others, Chromatin/Epigenetic
Bioactivity
GSK973 is a highly selective and orally bioavailable inhibitor that targets the second bromodomains (BD2s) of the BET family. It exhibits a pIC 50 of 7.8 and a pK d of 8.7 specifically for BRD4 BD2. Additionally, GSK973 demonstrates a remarkable selectivity of 1600-fold for BRD4 BD2 over BRD4 BD1. Moreover, it displays good potency against BRD2 BD2, BRD3 BD2, and BRDT BD2, with pIC 50 ranging from 7.4 to 7.8 and pK d ranging from 8.3 to 8.5.
Smiles
[H][C@@]12COC[C@]1([H])[C@H]2NC(=O)c1cc2[C@@H]([C@@H](CF)Oc2c(c1)C(=O)NC)c1ccccc1
Molecular Formula
C23H23FN2O4
Molecular Weight
410.445
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC202058L3V 200 µL
ORC1 (NM_004153) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
MBS7019014-01 0.02 mg
Recombinant Xenopus laevis Lysophosphatidic acid receptor 1-A (lpar1-a)
Sign In for Pricing
View Details MBS7019014-02 0.1 mg
Recombinant Xenopus laevis Lysophosphatidic acid receptor 1-A (lpar1-a)
Sign In for Pricing
View Details MBS7019014-03 5x 0.1 mg
Recombinant Xenopus laevis Lysophosphatidic acid receptor 1-A (lpar1-a)
Sign In for Pricing
View Details 
168644-ML650 100 µL
AMACR (Alpha-methylacyl-CoA Racemase, CBAS4, Da1-8, Macr1, RACE, RM, p504S) (MaxLight 650) discontinued
Sign In for Pricing
View Details